Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Quantum Biopharma (QNTM) Other Operating Expenses (2019 - 2025)

Quantum Biopharma's Other Operating Expenses history spans 7 years, with the latest figure at $937823.0 for Q4 2025.

  • On a quarterly basis, Other Operating Expenses rose 427.21% to $937823.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $2.4 million, a 1264.99% increase, with the full-year FY2025 number at $3.5 million, up 443.15% from a year prior.
  • Other Operating Expenses hit $937823.0 in Q4 2025 for Quantum Biopharma, down from $1.5 million in the prior quarter.
  • Over the last five years, Other Operating Expenses for QNTM hit a ceiling of $4.8 million in Q1 2023 and a floor of $177884.0 in Q4 2024.
  • Historically, Other Operating Expenses has averaged $2.3 million across 5 years, with a median of $1.5 million in 2025.
  • Biggest five-year swings in Other Operating Expenses: soared 306.7% in 2023 and later skyrocketed 427.21% in 2025.
  • Tracing QNTM's Other Operating Expenses over 5 years: stood at $4.0 million in 2021, then crashed by 70.41% to $1.2 million in 2022, then skyrocketed by 176.86% to $3.3 million in 2023, then plummeted by 94.57% to $177884.0 in 2024, then skyrocketed by 427.21% to $937823.0 in 2025.
  • Business Quant data shows Other Operating Expenses for QNTM at $937823.0 in Q4 2025, $1.5 million in Q1 2025, and $177884.0 in Q4 2024.